Private equity firm CVC Capital Partners is considering a take over of medical laser company Lumenis in a deal that could be worth up to $900 million, according to a report from CTech. The two parties are reportedly in advanced negotiations that would put the Israel-based medical and cosmetic laser biz under new ownership. Lumenis […]
Lumenis’ XIO buyout closes
Lumenis said it completed its $510 million take over by Hong-Kong based XIO group, according to an SEC filing posted yesterday. Lumenis makes energy-based medical devices for surgical, ophthalmological and aesthetic applications. Yokneam, Israel-based Lumenis will become a wholly-owned subsidiary of an Israel-based company that is indirectly wholly-owned by XIO, according to the SEC filing. Shareholders will receive a […]
Lumenis shareholders approve $510m XIO take over
Lumenis shareholders approved the company’s $510 million sale to Hong Kong-based XIO group, according to an SEC filing posted yesterday. Lumenis makes energy-based medical devices for surgical, ophthalmological and aesthetic applications. Yokneam, Israel-based Lumenis will become a wholly-owned subsidiary of an Israel-based company that is indirectly wholly-owned by XIO, according to the SEC filing. In June, Lumenis […]
Hong Kong’s Xio to pay $510m for Lumenis
Lumenis (NSDQ:LMNS) said today that it agreed to a $510 million acquisition bid from a Hong Kong-based “alternative investments” shop. Yokneam, Israel-based Lumenis, which raised $75 million in an initial public offering last year, was said in February to be in talks about a buyout by Chinese conglomerate Fosun for nearly $500 million. Today Lumenis said Xio Group put […]
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Report: Lumenis in talks to be acquired by Fosun for $480M
Lumenis Ltd., which raised nearly $100 million through an initial public offering on NASDAQ last year, is in talks to be acquired by Chinese conglomerate Fosun for nearly $500 million, according to the Israeli financial newspaper Calcalist.
Lumenis undercuts IPO price at $12 per share, shares gain nearly 9%
Lumenis Ltd. today priced its initial public offering at $12 per share, 20% under the low end of the prior $15-$17 range set by the Israeli maker of medical lasers.
Lumenis shares, trading under the "LMNS" symbol on the NASDAQ exchange, opened up 4.2% at $12.50 today and were fetching $13.05 apiece as of about 11:20 a.m., up 8.8%.
Lumenis sets $100M IPO terms
Lumenis Ltd. said it plans to sell 6.25 million shares at $15 to $17 apiece in its upcoming initial public offering.
That would bring in between $93.8 million and $106.3 million for the Israeli medical laser maker, which announced the IPO late last year.
Lumenis files for $115M IPO
Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million.
Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under the "LMNS" symbol.
Cambridge Heart chairman, ex-CEO both resign | Personnel Moves
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Lumenis wins U.S. & Japanese clearance for retinal laser treatment
Lumenis Ltd. announced today regulatory wins in the U.S. and Japan for its Array LaserLink pattern scanning device for multi-spot laser photocoagulation for use during retinal surgery.
The Array LaserLink, which turns an "examination slit lamp" into a medical laser, expands on the Lumenis laser system to deliver “pattern scanning capabilities, aimed to provide greater predictability in retinal treatments and presumably less collateral damage to the retina,” according to a press release.
MassDevice Network
@MassDevice
LinkedIn
YouTube